Injective vs Ethena Labs (USDTB) — how do they compare? Injective trades at Rp93,640 (market cap Rp9,29T, Rp1,86T 24h volume), while Ethena Labs (USDTB) trades at Rp18,001 (market cap Rp8,14T, Rp117,43jt 24h volume). The key difference: Injective and Ethena Labs (USDTB) are close in size by market cap, and Injective's circulating supply is 100M INJ versus 452,1M USDTB for Ethena Labs (USDTB). Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Ethena Labs (USDTB) for 23 Days on average.
| INJ | USDTB | |
|---|---|---|
Market Cap | Rp9,29T | Rp8,14T |
Volume (24h) | Rp1,86T | Rp117,43jt |
Circulating Supply | 100M INJ | 452,1M USDTB |
Typical Hold Time | 36 Days | 23 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
USDTB trades at Rp18,079 with a bullish technical signal from moving averages, though RSI_6 indicates overbought conditions. Support lies near Rp18,002, with resistance at Rp18,124. The token shows neutral oscillators but strong ADX signals for trend strength. Market cap stands at Rp13.12 trillion with a 23-day average hold time, suggesting moderate trader retention. No major protocol updates or ecosystem news were reported recently, keeping fundamentals static.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and regulatory uncertainty. Key opportunities lie in breakout above resistance, while overbought RSI and thin liquidity pose near-term threats. Investors should monitor exchange volumes and crypto market sentiment shifts for entry points.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →USDtb is a fiat-backed stablecoin pegged to the US dollar, similar to USDC or USDT, with unrestricted transferability. Backed primarily by BlackRock’s BUIDL (90% of reserves), it holds the highest BUIDL allocation of any stablecoin, enabling unmatched scalability.
Read more on USDTB →